Macleods Pharma USA, Inc. is voluntarily recalling approximately 8,015 packs of Candesartan Cilexetil (4 mg) prescription blood pressure tablets because the medication failed to meet laboratory specifications for impurities and degradation. These 30-count bottles were distributed nationwide in the United States and were manufactured by Macleods Pharmaceuticals Ltd. in India. Consumers who have these tablets should consult their doctor or pharmacist regarding their treatment and return the product to their pharmacy for a refund.
The tablets may contain impurities or degradation products that exceed safety limits. While this recall is considered low risk, consuming medication with failed impurity specifications means the drug's safety and effectiveness over time cannot be guaranteed.
Return unused product for refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.